Literature DB >> 17093010

Pharmacokinetics of bevacizumab in haemodialysis.

Nathalie Garnier-Viougeat, Olivier Rixe, Gilles Paintaud, David Ternant, Danielle Degenne, Roger Mouawad, Gilbert Deray, Hassane Izzedine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17093010     DOI： 10.1093/ndt/gfl664

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Authors:  Rong Deng; Yehong Wang; Mauricio Maia; Tracy Burgess; Jacqueline M McBride; X Charlene Liao; Jorge A Tavel; William D Hanley
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  A case report--treatment of metastatic colorectal cancer in a patient on hemodialysis.

Authors:  Ryan M Bolonesi; Jane E Rogers; Imad Shureiqi
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 3.  Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).

Authors:  Laura Cosmai; Maurizio Gallieni; Wanda Liguigli; Camillo Porta
Journal:  J Nephrol       Date:  2016-05-06       Impact factor: 3.902

4.  Safety and efficacy of molecularly targeted agents in patients with metastatic kidney cancer with renal dysfunction.

Authors:  Sachin Gupta; Venkata Parsa; Lance K Heilbrun; Daryn W Smith; Brenda Dickow; Elisabeth Heath; Ulka Vaishampayan
Journal:  Anticancer Drugs       Date:  2011-09       Impact factor: 2.248

Review 5.  Renal effects of targeted anticancer therapies.

Authors:  Camillo Porta; Laura Cosmai; Maurizio Gallieni; Paolo Pedrazzoli; Fabio Malberti
Journal:  Nat Rev Nephrol       Date:  2015-03-03       Impact factor: 28.314

Review 6.  Systemic Treatments for Lung Cancer Patients Receiving Hemodialysis.

Authors:  Tzewah V Leung; Mitchell E Hughes; Christine G Cambareri; Daniel J Rubin; Beth Eaby-Sandy
Journal:  J Adv Pract Oncol       Date:  2018-09-01

7.  Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab.

Authors:  Toshimitsu Tanaka; Hiroyuki Suzuki; Tomoyuki Ushijima; Sachiko Nagasu; Yoshito Akagi; Takumi Kawaguchi; Keisuke Miwa
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 8.  Treatment of patients with metastatic renal cell carcinoma undergoing hemodialysis: case report of two patients and short literature review.

Authors:  John Syrios; Georgios Kechagias; Nicolas Tsavaris
Journal:  BMC Nephrol       Date:  2013-04-12       Impact factor: 2.388

Review 9.  Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.

Authors:  Hsuan Yeh; Chung-Cheng Chiang; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.